Package 63323-193-52

Brand: irinotecan hydrochloride

Generic: irinotecan hydrochloride
NDC Package

Package Facts

Identity

Package NDC 63323-193-52
Digits Only 6332319352
Product NDC 63323-193
Product ID 63323-193_4e0a18c8-35aa-447c-bd91-b81d7d494d8e
Description

1 VIAL in 1 BOX (63323-193-52) / 2 mL in 1 VIAL

Marketing

Marketing Status
Marketed Since 2009-04-01
Brand irinotecan hydrochloride
Generic irinotecan hydrochloride
Sample Package No

Linked Drug Pages (1)

Irinotecan Hydrochloride ndc-match (0.95)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["INTRAVENOUS"], "spl_id": "4e0a18c8-35aa-447c-bd91-b81d7d494d8e", "openfda": {"upc": ["0363323193522", "0363323193553"], "unii": ["042LAQ1IIS"], "rxcui": ["1726319", "1726324"], "spl_set_id": ["ee45f127-8450-4455-a945-a1f5707f1d39"], "manufacturer_name": ["Fresenius Kabi USA, LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 VIAL in 1 BOX (63323-193-52)  / 2 mL in 1 VIAL", "package_ndc": "63323-193-52", "marketing_start_date": "20090401"}, {"sample": false, "description": "1 VIAL in 1 BOX (63323-193-55)  / 5 mL in 1 VIAL", "package_ndc": "63323-193-55", "marketing_start_date": "20090401"}], "brand_name": "Irinotecan Hydrochloride", "product_id": "63323-193_4e0a18c8-35aa-447c-bd91-b81d7d494d8e", "dosage_form": "INJECTION, SOLUTION", "pharm_class": ["Topoisomerase Inhibitor [EPC]", "Topoisomerase Inhibitors [MoA]"], "product_ndc": "63323-193", "generic_name": "IRINOTECAN HYDROCHLORIDE", "labeler_name": "Fresenius Kabi USA, LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Irinotecan Hydrochloride", "active_ingredients": [{"name": "IRINOTECAN HYDROCHLORIDE", "strength": "20 mg/mL"}], "application_number": "ANDA077776", "marketing_category": "ANDA", "marketing_start_date": "20090401", "listing_expiration_date": "20261231"}